No Data
Summit Therapeutics Q1 Loss Widens; Cash Equivalents Drop
Earnings Flash (SMMT) Summit Therapeutics Q1 Adjusted Loss $0.07 Vs. $0.05 Loss Year Ago
Summit Therapeutics | 10-Q: Quarterly report
Express News | Summit Therapeutics Q1 Operating Expenses USD 66.8 Million
Express News | Summit Therapeutics Q1 EPS USD -0.09
Express News | Summit Therapeutics Q1 Net Income USD -62.9 Million